Trained immunity: A smart way to enhance innate immune defence

Molecular Immunology

Volumn 68, Issue 1, 2015, Pages 40-44

  van der Meer, Jos W M ^a   Joosten, Leo A B ^a   Riksen, Niels ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG; Candida; Epigenetics; Innate immunity; Trained immunity; Vaccination

Indexed keywords

BETA GLUCAN; DECTIN 1; BCG LIPOPOLYSACCHARIDE; CHROMATIN; CLEC7A PROTEIN, HUMAN; FUNGAL POLYSACCHARIDE; HISTONE; LECTIN; LIPOPOLYSACCHARIDE;

ATHEROGENESIS; CANDIDA; CELL ACTIVATION; CELL METABOLISM; CLINICAL MEDICINE; CYTOKINE PRODUCTION; EPIGENETICS; GLYCOLYSIS; HISTONE METHYLATION; HUMAN; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VACCINATION; ADAPTIVE IMMUNITY; ANIMAL; CHROMATIN; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; BETA-GLUCANS; CHROMATIN; EPIGENESIS, GENETIC; FUNGAL POLYSACCHARIDES; HISTONES; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; MONOCYTES; SIGNAL TRANSDUCTION;

EID: 84952001204     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.06.019     Document Type: Review

References (30)

1. Aleem E. β-Glucans and their applications in cancer therapy: focus on human studies. Anticancer Agents Med. Chem. 2013, 13:709-719.
2. Bekkering S., Joosten L.A.B., van der Meer J.W.M., Netea M.G., Riksen N.P. Trained innate immunity and atherosclerosis. Curr. Opin. Lipidol. 2013, 24:487-492. 10.1097/MOL.0000000000000023.
3. Bekkering S., Quintin J., Joosten L.A.B., van der Meer J.W.M., Netea M.G., Riksen N.P. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1731-1738. 10.1161/ATVBAHA.114.303887.
4. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 1986, 51:668-674.
5. Bistoni F., Verducci G., Perito S., Vecchiarelli A., Puccetti P., Marconi P., Cassone A. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J. Med. Vet. Mycol. 1988, 26:285-299.
6. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896. 10.1038/ni.1937.
7. Bowdish D.M.E., Loffredo M.S., Mukhopadhyay S., Mantovani A., Gordon S. Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes Infect. 2007, 9:1680-1687. 10.1016/j.micinf.2007.09.002.
8. Buffen K., Oosting M., Quintin J., Ng A., Kleinnijenhuis J., Kumar V., van de Vosse E., Wijmenga C., van Crevel R., Oosterwijk E., Grotenhuis A.J., Vermeulen S.H., Kiemeney L.A., van de Veerdonk F.L., Chamilos G., Xavier R.J., van der Meer J.W.M., Netea M.G., Joosten L.A.B. Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog. 2014, 10:e1004485. 10.1371/journal.ppat.1004485.
9. Cheng S.-C., Quintin J., Cramer R.A., Shepardson K.M., Saeed S., Kumar V., Giamarellos-Bourboulis E.J., Martens J.H.A., Rao N.A., Aghajanirefah A., Manjeri G.R., Li Y., Ifrim D.C., Arts R.J.W., van der Meer B.M.J.W., Deen P.M.T., Logie C., O'Neill L.A., Willems P., van de Veerdonk F.L., van der Meer J.W.M., Ng A., Joosten L.A.B., Wijmenga C., Stunnenberg H.G., Xavier R.J., Netea M.G. mTOR- and HIF-1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014, 345:1250684. 10.1126/science.1250684.
10. Chester K.S. The problem of acquired physiological immunity in plants. Q. Rev. Biol. 1933, 8:275-324.
11. Durrant W.E., Dong X. Systemic acquired resistance. Annu. Rev. Phytopathol. 2004, 42:185-209.
12. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978. 10.1038/nature05836.
13. Garly M.-L., Martins C.L., Balé C., Baldé M.A., Hedegaard K.L., Gustafson P., Lisse I.M., Whittle H.C., Aaby P. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?. Vaccine 2003, 21:2782-2790.
14. Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013, 13:862-874. 10.1038/nri3552.
15. Ifrim D., Quintin J., Meerstein-Kessel L., Plantinga T., Joosten L., Meer, van der J., van de Veerdonk, Frank Netea M. Defective trained immunity in patients with STAT1-dependent chronic mucocutaneaous candidiasis. Clin. Exp. Immunol. 2015, (PMID: 25880788). 10.1111/cei.12642.
16. Kleinnijenhuis J., Quintin J., Preijers F., Benn C.S., Joosten L.A.B., Jacobs C., van Loenhout J., Xavier R.J., Aaby P., van der Meer J.W.M., van Crevel R., Netea M.G. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J. Innate Immun. 2014, 6:152-158. 10.1159/000355628.
17. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A.B., Ifrim D.C., Saeed S., Jacobs C., van Loenhout J., de Jong D., Stunnenberg H.G., Xavier R.J., van der Meer J.W.M., van Crevel R., Netea M.G. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17537-17542. 10.1073/pnas.1202870109.
18. Lamb D.J., Eales L.J., Ferns G.A. Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 1999, 143:105-113.
19. Lamb D.J., Ferns G.A. Infection, immunisation and atherosclerosis: is there a link?. Vaccine 1999, 17:559-564.
20. Leentjens J., Quintin J., Gerretsen J., Kox M., Pickkers P., Netea M.G. The effects of orally administered beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study. PLOS ONE 2014, 9:e108794. 10.1371/journal.pone.0108794.
21. Netea M.G., Quintin J., van der Meer J.W.M. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011, 9:355-361. 10.1016/j.chom.2011.04.006.
22. O'Connor S., Taylor C., Campbell L.A., Epstein S., Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg. Infect. Dis. 2001, 7:780-788. 10.3201/eid0705.010503.
23. O'Neill L.A.J., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013, 493:346-355. 10.1038/nature11862.
24. Pham L.N., Dionne M.S., Shirasu-Hiza M., Schneider D.S. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog. 2007, 3:e26. 10.1371/journal.ppat.0030026.
25. Quintin J., Saeed S., Martens J.H.A., Giamarellos-Bourboulis E.J., Ifrim D.C., Logie C., Jacobs L., Jansen T., Kullberg B.-J., Wijmenga C., Joosten L.A.B., Xavier R.J., van der Meer J.W.M., Stunnenberg H.G., Netea M.G. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012, 12:223-232. 10.1016/j.chom.2012.06.006.
26. Rosenfeld M.E., Campbell L.A. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb. Haemost. 2011, 106:858-867. 10.1160/TH11-06-0392.
27. Ross R. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 1986, 314:488-500. 10.1056/NEJM198602203140806.
28. Saeed S., Quintin J., Kerstens H.H.D., Rao N.A., Aghajanirefah A., Matarese F., Cheng S.-C., Ratter J., Berentsen K., van der Ent M.A., Sharifi N., Janssen-Megens E.M., Ter Huurne M., Mandoli A., van Schaik T., Ng A., Burden F., Downes K., Frontini M., Kumar V., Giamarellos-Bourboulis E.J., Ouwehand W.H., van der Meer J.W.M., Joosten L.A.B., Wijmenga C., Martens J.H.A., Xavier R.J., Logie C., Netea M.G., Stunnenberg H.G. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014, 345:1251086. 10.1126/science.1251086.
29. Van't Wout J.W., Poell R., van Furth R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand. J. Immunol. 1992, 36:713-719.
30. Vecchiarelli A., Cenci E., Puliti M., Blasi E., Puccetti P., Cassone A., Bistoni F. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state. Cell. Immunol. 1989, 124:334-344.